Chelohart

Chelohart is a natural peptide bioregulator (Cytomax) containing Peptide Complex A-14, extracted from the cardiac muscle of young animals (typically calves under 10 months). Developed by Professor Vladimir Khavinson and researchers at the St. Petersburg Institute of Bioregulation and Gerontology, it specifically targets cardiomyocytes (heart muscle cells) to support healthy cellular function, protein synthesis, and myocardial performance as part of age-related wellness protocols.

Unlike broad cardiovascular supplements, Chelohart is tissue-specific. It focuses on the heart muscle itself rather than blood vessels or systemic circulation.

What Is Chelohart?

Chelohart belongs to the Cytomax family of natural short-chain peptide complexes (as opposed to faster-acting synthetic Cytogens). These peptides (typically 2–7 amino acid residues) are designed to enter cells, interact with DNA in a tissue-selective manner, and help restore more youthful patterns of gene expression and protein synthesis in target tissues.

Key facts:

• Active ingredient: Peptide Complex A-14 (cardiac muscle peptides)
• Typical capsule strength: Often 10 mg active peptides per capsule (formulations vary by supplier; some list 200 mg total capsule weight)
• Form: Oral capsules (no injection required)
• Category: Biologically active food supplement / dietary supplement
• Manufacturing note: Produced under quality standards associated with the Khavinson bioregulator line (check individual sellers for GMP details)

It is not a medication and is not intended to diagnose, treat, cure, or prevent any disease.

How Chelohart Works at the Cellular Level

As people age (particularly after 50), protein synthesis and cellular metabolism in cardiomyocytes slow. These long-lived cells do not readily regenerate like many other tissues, so declining efficiency can lead the heart to work harder for the same output.

Chelohart is proposed to support:

• Gene expression & protein synthesis — Short peptides may influence DNA regions involved in producing proteins needed for contraction, energy production, and repair.
• Mitochondrial function & energy production — Heart muscle cells are mitochondria-rich; better cellular metabolism may support consistent energy for each beat.
• Cellular repair processes — Helps maintain the signaling environment for clearing damaged proteins and supporting structural integrity of existing cardiomyocytes.
• Tissue-specific regulation — Targets myocardial cells rather than providing general antioxidant or circulatory support.

Effects are described as gradual and potentially longer-lasting after a course ends, consistent with the broader Khavinson bioregulator approach of pulsed (not continuous) use.

Potential Benefits & Intended Uses

According to manufacturer and supplier information within the Khavinson tradition, Chelohart is positioned to support:

• Healthy myocardial (heart muscle) function and contractile activity
• Age-related cardiac cellular efficiency
• Recovery and resilience under physical stress or intense exertion
• Overall cardiovascular wellness protocols (often combined with vessel-supporting peptides)
• Prevention-oriented heart support in aging adults

Listed areas of interest in product materials include arterial hypertension contexts, chronic heart failure support (as adjunct), ischemic considerations, post-infarction cardiosclerosis, cardiomyopathy, myocarditis, and related myocardial conditions — always as a dietary supplement, not a treatment.

Important: These are traditional/research-context claims. Individual results vary. Consult a healthcare professional, especially if you have diagnosed heart conditions or take medications.

Chelohart vs. Ventfort (and Cardio Combinations)

• Chelohart (A-14) → Targets heart muscle (cardiomyocytes)
• Ventfort (A-3) → Targets blood vessel tissue (tone, flexibility, wall support)

Many Khavinson-style protocols combine them (sometimes with Vladonix for immune/thymic support) for complementary cardiovascular coverage — heart muscle + vessels. Combination products such as “Cardio 3” exist in some lines.

Chelohart (natural complex) is often contrasted with synthetic cardiac peptides like Cardiogen: the natural version is considered broader and more sustained; synthetics may act faster.

Dosage & How to Take Chelohart

Standard protocols from supplier and community sources (aligned with Khavinson-style courses):

• Typical dose: 1–2 capsules, 1–2 times daily (often with or before meals)
• Course length: 10 days (20-capsule packs) or 30 days (60-capsule packs)
• Frequency of courses: Often 1–3 times per year, or as advised; effects are intended to persist after the course
• Age: Generally for adults (some labels note 14+ or 18+); not for children
• Administration: Oral only

In more intensive or chronic situations, longer or repeated courses may be suggested alongside other organ-specific bioregulators, ideally under professional guidance.

Always follow the specific product label and consult a doctor before starting, particularly with existing health conditions or medications.

Safety, Side Effects & Contraindications

Khavinson bioregulators are generally described as well-tolerated, non-toxic, non-allergenic, and non-addictive in the available literature and long-term Russian clinical observations. Short peptides clear relatively quickly and are less likely to provoke immune responses than larger proteins.

• Reported side effects: Minimal to none in published materials
• Contraindications: Hypersensitivity to components; use caution (or consult a doctor) during pregnancy and breastfeeding
• Not a substitute for prescribed heart medications or medical care

Evidence for the broader peptide bioregulator class includes multi-year observational data in elderly patients showing favorable safety and associations with improved functional markers, though independent Western large-scale RCTs remain limited.

Who Might Consider Chelohart?

• Adults seeking targeted support for heart muscle cellular health as part of healthy aging
• Those already using or interested in Khavinson-style peptide protocols (especially combined with vascular support)
• Individuals under high physical demand who want myocardial resilience support
• People exploring complementary wellness approaches alongside conventional lifestyle measures (exercise, diet, blood pressure management, etc.)

It is not a first-line treatment for acute or diagnosed cardiac disease.